Skip to main content

Published locations for Alemtuzumab May Provide Greater Benefit Than Interferon Beta-1a for Treatment-Naïve Patients With MS—Results From the CARE-MS I Study

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Alemtuzumab May Provide Greater Benefit Than Interferon Beta-1a for Treatment-Naïve Patients With MS—Results From the CARE-MS I Study

User login

  • Reset your password
  • /content/alemtuzumab-may-provide-greater-benefit-interferon-beta-1a-treatment-naive-patients-ms
  • /neurologyreviews/article/73505/multiple-sclerosis/alemtuzumab-may-provide-greater-benefit-interferon
  • /multiplesclerosishub/article/73505/multiple-sclerosis/alemtuzumab-may-provide-greater-benefit
  • /neurology/article/73505/multiple-sclerosis/alemtuzumab-may-provide-greater-benefit-interferon-beta
  • /neurology/msresourcecenter/article/73505/multiple-sclerosis/alemtuzumab-may-provide-greater-benefit